A Gene Transfer Therapy Study in Participants With Duchenne Muscular Dystrophy
Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!
Summary
- Eligibility
- for males ages 4-7 (full criteria)
- Location
- at Sacramento, California and other locations
- Dates
- study startedcompletion around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Sarepta Therapeutics, Inc.
- Links
- Sign up for this study
- ID
- NCT05096221
- Phase
- Phase 3 Duchenne Muscular Dystrophy Research Study
- Study Type
- Interventional
- Participants
- About 126 people participating
- Last Updated